SEC Form 4 · accession 0001209191-15-084995
ACURA PHARMACEUTICALS, INC · ACUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Bradley Rivet
Officer — VP Marketing
Period of report
Dec 10, 2015
Accepted (ET)
Dec 14, 2015 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF3,F1,F2 | $2.01 | Dec 10, 2015 | A | 20,000 | A | — | Dec 9, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Exercise price is closing price of Issuer's common stock on December 10, 2015.
- F2one-twenty-fourth of shares underlying options vest and are exercisable on the last day of each month commencing December 31, 2015 and ending on November 30, 2017.
- F3Not Applicable.